MELPHALAN (MEL fa lan) is a chemotherapy drug. It slows the growth of cancer cells. This medicine is used to treat multiple myeloma.
Melphalan (trade name Alkeran, in former USSR also known as Sarcolysin) is a
chemotherapy drug belonging to the class of nitrogen mustard alkylating agents.
Drug type: Melphalan is an anti-cancer ("antineoplastic" or "cytotoxic")
chemotherapy drug. This medication is classified as an "alkylating agent." (For
more detail ...
Melphalan can cause a severe decrease in the number of blood cells in your
bone marrow. This may cause certain symptoms and may increase the risk that
No tome su medicamento con una frecuencia mayor a la indicada. Necesita saber si usted presenta alguno de los siguientes problemas o situaciones:
una reacción alérgica o inusual al melfalán, a otros agentes quimioterapéuticos, a otros medicamentos, alimentos, colorant... More »
Get information about Melphalan (Alkeran ®), which is a chemotherapy drug
usually given to treat multiple myeloma, and occasionally melanoma and ovarian
Jan 23, 2014 ... The chemotherapy drug melphalan can treat myeloma, advanced ovarian cancer
and advanced breast cancer. The possible side effects ...
Easy to read patient leaflet for melphalan. Includes indications, proper use,
special instructions, precautions, and possible side effects.
Jun 8, 2011 ... WARNING. ALKERAN (melphalan) should be administered under the
supervision of a qualified physician experienced in the use of cancer ...
Apr 16, 2014 ... Consumer information about the medication MELPHALAN - ORAL (Alkeran),
includes side effects, drug interactions, recommended dosages, ...